Steroid-responsive confusion associated with thyroiditis.
Kinrys
G
G
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN 55905, USA.
Bostwick
J M
JM
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D003221:Confusion / Q000209:etiology*; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008775:Methylprednisolone / Q000008:administration & dosage / Q000627:therapeutic use*; D008875:Middle Aged; D018696:Neuroprotective Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D020258:Neurotoxicity Syndromes / Q000150:complications / Q000188:drug therapy* / Q000209:etiology* / Q000378:metabolism; D011241:Prednisone / Q000008:administration & dosage / Q000627:therapeutic use*; D011595:Psychomotor Agitation / Q000209:etiology; D013967:Thyroiditis, Autoimmune / Q000150:complications / Q000175:diagnosis* / Q000188:drug therapy; D016896:Treatment Outcome
D000893:Anti-Inflammatory Agents; D005938:Glucocorticoids; D018696:Neuroprotective Agents; D011241:Prednisone; D008775:Methylprednisolone